Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand
of the changed medicine which was referred to the Minister of Health under the provisions of section 24 (5) of the Act and is set out in the Schedule hereto:
Schedule
Product: Vaxigrip vaccine
Active Ingredients: Influenza virus A/Wellington/I/2004(H3N2)-like strain 10µg/dose
Influenza virus B/Shanghai/361/2002-like strain 15µg/dose
Influenza virus haemagglutin type A/New Caledonia/20/99 H1N1-like strain 15µg/dose
Dosage Form: Solution for injection
New Zealand Sponsor: Aventis Pharma Limited
Manufacturers: Aventis Pasteur SA, Marcy L’Etoile, France
Aventis Pasteur SA, Val-De-Reuil Cedex, France
Note: This medicine has provisional consent that expires on 31 March 2006.
Dated this 3rd day of May 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).